|
|||||
|
|
Anti-IL-10 therapeutic strategy using the immunomodulator AS101 in protecting mice from sepsis-induced death: dependence on timing of immunomodulating intervention |
|
| Authors: | Kalechman Yona Gafter Uzi Gal Rivka Rushkin Galit Yan Donghong Albeck Michael Sredni Benjamin |
| Institution: | C.A.I.R. Institute, Faculty of Life Sciences, Bar Ilan University, Ramat Gan, Israel. |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |